Assertio Holdings (ASRT) Retained Earnings (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Retained Earnings came in at -$722.4 million in Q1 2026, down 5.2% year-on-year from -$762.0 million in Q1 2025, and down 2.68% quarter-over-quarter from -$703.5 million in Q4 2025.
Assertio Holdings (ASRT) Retained Earnings (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Retained Earnings across 8 years of filings, most recently posting -$722.4 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$722.4 million, down 5.2% year-over-year; the trailing twelve-month figure through Mar 2026 was -$722.4 million (down 5.2% YoY), and the FY2025 annual result was -$703.5 million, down 4.51% from the prior year.
- Retained Earnings came in at -$722.4 million for Q1 2026 at Assertio Holdings, down from -$703.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$314.6 million in Q2 2023 to a low of -$722.4 million in Q1 2026.
- The 5-year median for Retained Earnings is -$656.1 million (2024), against an average of -$564.8 million.
- Across the five-year window, Retained Earnings climbed 25.54% in 2022 and plunged 109.69% in 2024, its largest moves.
- Assertio Holdings' Retained Earnings stood at -$319.6 million in 2022, then tumbled by 103.86% to -$651.5 million in 2023, then fell by 3.31% to -$673.1 million in 2024, then declined by 4.51% to -$703.5 million in 2025, then declined by 2.68% to -$722.4 million in 2026.
- The last three Retained Earnings figures came in at -$722.4 million (Q1 2026), -$703.5 million (Q4 2025), and -$691.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | -722.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -722.36 Mn |
| Dec 31, 2025 | -703.50 Mn |
| Sep 30, 2025 | -691.57 Mn |
| Jun 30, 2025 | -703.02 Mn |
| Mar 31, 2025 | -686.67 Mn |
| Dec 31, 2024 | -673.12 Mn |
| Sep 30, 2024 | -662.65 Mn |
| Jun 30, 2024 | -659.73 Mn |
| Mar 31, 2024 | -656.05 Mn |
| Dec 31, 2023 | -651.54 Mn |
| Sep 30, 2023 | -594.16 Mn |
| Jun 30, 2023 | -314.62 Mn |
| Mar 31, 2023 | -323.09 Mn |
| Dec 31, 2022 | -319.60 Mn |
| Sep 30, 2022 | -408.15 Mn |
| Jun 30, 2022 | -412.33 Mn |
| Mar 31, 2022 | -420.16 Mn |
| Dec 31, 2021 | -429.23 Mn |
| Sep 30, 2021 | -433.83 Mn |
| Jun 30, 2021 | -437.57 Mn |